InSphero Expands 3D Cell Model Leadership with Acquisition of DOPPL SA and Sun Bioscience Gri3D® Technology
InSphero acquires DOPPL SA to unite spheroid and organoid technology, creating a comprehensive 3D in vitro model platform for drug discovery and safety testing. SCHLIEREN, ZüRICH, SWITZERLAND, November 11, 2025 /EINPresswire.com/ -- InSphero AG, …